These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 33378180)

  • 21. Antinuclear antibody (ANA) testing in patients treated with biological DMARDs: is it useful?
    García-De LaTorre I; García-Valladares I
    Curr Rheumatol Rep; 2015 Apr; 17(4):23. PubMed ID: 25854488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of T-cell responses by anti-tumor necrosis factor treatments in rheumatoid arthritis: a review.
    Davignon JL; Rauwel B; Degboé Y; Constantin A; Boyer JF; Kruglov A; Cantagrel A
    Arthritis Res Ther; 2018 Oct; 20(1):229. PubMed ID: 30314507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A benzothiophene inhibitor of mitogen-activated protein kinase-activated protein kinase 2 inhibits tumor necrosis factor alpha production and has oral anti-inflammatory efficacy in acute and chronic models of inflammation.
    Mourey RJ; Burnette BL; Brustkern SJ; Daniels JS; Hirsch JL; Hood WF; Meyers MJ; Mnich SJ; Pierce BS; Saabye MJ; Schindler JF; South SA; Webb EG; Zhang J; Anderson DR
    J Pharmacol Exp Ther; 2010 Jun; 333(3):797-807. PubMed ID: 20237073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting TRAF6 E3 ligase activity with a small-molecule inhibitor combats autoimmunity.
    Brenke JK; Popowicz GM; Schorpp K; Rothenaigner I; Roesner M; Meininger I; Kalinski C; Ringelstetter L; R'kyek O; Jürjens G; Vincendeau M; Plettenburg O; Sattler M; Krappmann D; Hadian K
    J Biol Chem; 2018 Aug; 293(34):13191-13203. PubMed ID: 29950522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reprint of BMCL_19101.
    Lansdell TA; O'Reilly S; Woolliscroft T; Azevedo LM; Kahlon DK; Hovde S; McCormick JJ; Henry RW; Cornicelli JA; Tepe JJ
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6821-4. PubMed ID: 23083981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.
    Smolen JS; Kay J; Doyle MK; Landewé R; Matteson EL; Wollenhaupt J; Gaylis N; Murphy FT; Neal JS; Zhou Y; Visvanathan S; Hsia EC; Rahman MU;
    Lancet; 2009 Jul; 374(9685):210-21. PubMed ID: 19560810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor necrosis factor receptor pre-ligand assembly domain is an important therapeutic target in inflammatory arthritis.
    Deng GM
    BioDrugs; 2007; 21(1):23-9. PubMed ID: 17263587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and synthesis of orally active inhibitors of TNF synthesis as anti-rheumatoid arthritis drugs.
    Chen JJ; Dewdney N; Lin X; Martin RL; Walker KA; Huang J; Chu F; Eugui E; Mirkovich A; Kim Y; Sarma K; Arzeno H; Van Wart HE
    Bioorg Med Chem Lett; 2003 Nov; 13(22):3951-4. PubMed ID: 14592482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PET/CT Imaging of Human TNFα Using [
    Beckford-Vera DR; Gonzalez-Junca A; Janneck JS; Huynh TL; Blecha JE; Seo Y; Li X; VanBrocklin HF; Franc BL
    Mol Imaging Biol; 2020 Feb; 22(1):105-114. PubMed ID: 31065895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases.
    Williams RO; Paleolog E; Feldmann M
    Curr Opin Pharmacol; 2007 Aug; 7(4):412-7. PubMed ID: 17627887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of TNFalpha blockade on the antinuclear antibody profile in patients with chronic arthritis: biological and clinical implications.
    De Rycke L; Baeten D; Kruithof E; Van den Bosch F; Veys EM; De Keyser F
    Lupus; 2005; 14(12):931-7. PubMed ID: 16425572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biologics in the treatment of transplant rejection and ischemia/reperfusion injury: new applications for TNFalpha inhibitors?
    Pascher A; Klupp J
    BioDrugs; 2005; 19(4):211-31. PubMed ID: 16128605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel inhibitor of I-kappaB kinase beta ameliorates experimental arthritis through downregulation of proinflammatory cytokines in arthritic joints.
    Tanaka S; Toki T; Yokoyama M; Shimizu H; Yamasaki T; Yoneda Y; Muro F; Yasukochi T; Iimura S; Morishita K
    Biol Pharm Bull; 2014; 37(1):87-95. PubMed ID: 24389485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of MAPKs and NF-kappaB in tumor necrosis factor alpha-induced vascular cell adhesion molecule 1 expression in human rheumatoid arthritis synovial fibroblasts.
    Luo SF; Fang RY; Hsieh HL; Chi PL; Lin CC; Hsiao LD; Wu CC; Wang JS; Yang CM
    Arthritis Rheum; 2010 Jan; 62(1):105-16. PubMed ID: 20039412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased risk of developing Crohn's disease or ulcerative colitis in 17 018 patients while under treatment with anti-TNFα agents, particularly etanercept, for autoimmune diseases other than inflammatory bowel disease.
    Korzenik J; Larsen MD; Nielsen J; Kjeldsen J; Nørgård BM
    Aliment Pharmacol Ther; 2019 Aug; 50(3):289-294. PubMed ID: 31267570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TNF‑α increases inflammatory factor expression in synovial fibroblasts through the toll‑like receptor‑3‑mediated ERK/AKT signaling pathway in a mouse model of rheumatoid arthritis.
    Yu FY; Xie CQ; Jiang CL; Sun JT; Huang XW
    Mol Med Rep; 2018 Jun; 17(6):8475-8483. PubMed ID: 29693122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How does infliximab work in rheumatoid arthritis?
    Maini RN; Feldmann M
    Arthritis Res; 2002; 4 Suppl 2(Suppl 2):S22-8. PubMed ID: 12110154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biologics targeted at TNF: design, production and challenges.
    Gatto B
    Reumatismo; 2006; 58(2):94-103. PubMed ID: 16829986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis.
    Dai SM; Matsuno H; Nakamura H; Nishioka K; Yudoh K
    Arthritis Rheum; 2004 Feb; 50(2):432-43. PubMed ID: 14872485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computational design and optimization of novel d-peptide TNFα inhibitors.
    Yang W; Zhang Q; Zhang C; Guo A; Wang Y; You H; Zhang X; Lai L
    FEBS Lett; 2019 Jun; 593(12):1292-1302. PubMed ID: 31102258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.